Skip to main content
Premium Trial:

Request an Annual Quote

Response Genetics Warned by Nasdaq for Non-compliance with Listing Rule

NEW YORK (GenomeWeb) — Response Genetics has been warned by Nasdaq that it is not in compliance with a rule to remain listing on the Nasdaq Capital Market, the company recently disclosed in a document filed with the US Securities and Exchange Commission.

Nasdaq sent a letter to the firm in late November saying it does not meet a listing requirement calling for a minimum of $2.5 million stockholders' equity. For the third quarter ended Sept. 30, Response Genetics had shareholders' equity of about $2.0 million, according to the firm's Form 10-Q. 

The company has 45 days to submit a plan to regain compliance with the Nasdaq listing rule, and said in the SEC document that it is working on such a plan. Its deadline for submitting the plan is Jan. 8, 2015.

 

 

 

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.